G. Trotti - Academia.edu (original) (raw)
Papers by G. Trotti
Earth and Space 2021, 2021
The paper is concerned with the design of pneumatic structures which can be sent to the surface o... more The paper is concerned with the design of pneumatic structures which can be sent to the surface of the moon in a relatively small package and then opened to provide a large pressurized volume with life support systems to support a population of 12 people. A proposed system consists primarily of a Kevlar membrane which will support the internal pressures of the environment, a rigid pallet which will house all the life-support systems, and wall foam which provides sound and temperature insulation. The modules would be covered by three meters of lunar soil for radiation and temperature insulation. Site preparation, module connection, and characteristics of different modules are considered.
AIP Conference Proceedings, 2007
Revolutionary Design for Astronaut Exploration Beyond the Bio‐Suit System. [AIP Conference Proc... more Revolutionary Design for Astronaut Exploration Beyond the Bio‐Suit System. [AIP Conference Proceedings 880, 975 (2007)]. Dava J. Newman, Marita Canina, Guillermo L. Trotti. Abstract. ... In many respects, the Bio‐Suit System mimics Nature (biomimetics). ...
An architectural approach to the evolutionary growth of an orbiting space station from a small ma... more An architectural approach to the evolutionary growth of an orbiting space station from a small manned satellite to a fully independent, self-sustainable space colony facility is presented. Social and environmental factors, ease of transportation via the space shuttle, and structural design are considered.
42nd International Conference on Environmental Systems, 2012
Extravehicular activity (EVA) is one of the most critical enabling capabilities for human spacefl... more Extravehicular activity (EVA) is one of the most critical enabling capabilities for human spaceflight. Performing EVA is both technically challenging and physically demanding, requiring many hours of training and detailed preparation. As a result of working and training in the extravehicular mobility unit (EMU) spacesuit, many astronauts sustain musculoskeletal and minor injuries. Although injuries are typically minor and self-limited, they have the potential to impact mission success. We outline our research methodology to investigate EVA injury ultimately providing solutions that can be implemented both in the EMU and in future spacesuit designs. We review the issues and mechanisms causing injury as documented in the literature. The result of this work will be an injury database with input from many NASA stakeholders. We also highlight our work to model the astronaut performing realistic EVA motions to study the interaction between the person and the suit. Spacesuit models of the EMU and Mark III spacesuits will be used in combination with a human body model driven by the biomechanics of EVA motions. We will investigate joint torque, muscle activation, and contact pressure between the body and suit. This modeling effort informs our spacesuit injury countermeasure designs and recommendations. We present our design process for protection devices that ameliorate current astronaut suitinduced injuries.
2006 3rd IEEE/EMBS International Summer School on Medical Devices and Biosensors, 2006
... donning. This system is designed to be embedded in Bio-Suit, a revolutionary space suit conce... more ... donning. This system is designed to be embedded in Bio-Suit, a revolutionary space suit concept developed for many years by Prof. Dava ... exploration. I.Bio-SUIT SYSTEM The Bio-Suit System is a project developed by Prof. Dava ...
Extravehicular Activity (EVA) is among the most challenging activities in human spaceflight. Main... more Extravehicular Activity (EVA) is among the most challenging activities in human spaceflight. Maintaining astronaut health and comfort inside the spacesuit is critical to accomplish the tasks required for the mission. However, the current Extravehicular Mobility Unit (EMU) spacesuit causes many astronauts minor musculoskeletal injuries and discomfort, which could lead to suboptimal EVA performance and could impact mission success. This research effort highlights our effort to create a spacesuit injury and discomfort database to better track injuries and countermeasures. The database is developed as part of our broader investigation of " Spacesuit Trauma Countermeasure System Development ". The primary objective of the astronaut-spacesuit injury database is to gain insight into the mechanisms causing spacesuit injuries. The database is compiled from a variety of sources, such as existing databases and publications, oral histories, and astronaut debriefs. Once completely asse...
British Journal of Cancer, 1996
In a multicentre study, 83 patients with advanced and previously uniformly treated multiple myelo... more In a multicentre study, 83 patients with advanced and previously uniformly treated multiple myeloma (MM) were randomised between cyclophosphamide (600 mg m-2) and epirubicin (70 mg m-2), administered every 3 weeks for three courses and both associated with prednisone and interferon-a2b. Both regimens were administered on an outpatient basis and had low haematological toxicity. Clinical results were similar. Overall response rate (43%) and median response and survival (5.9 and 14.1 months respectively) compare well with those obtained with more aggressive chemotherapy schedules.
Tumori
The neutropenia induced by six courses of an intensified FEC regimen is expected to be checked by... more The neutropenia induced by six courses of an intensified FEC regimen is expected to be checked by early primary administration of G-CSF which is stopped eight days before the next chemotherapy course. Less information is available about megakaryocytic and erythroid toxicity over six courses. Sixty-six consecutive patients with metastatic breast cancer completed six courses of a randomized treatment with two FEC regimens administered every 21 days, in which 600 mg/m2 of cyclophosphamide and 5-FUwas associated with 60 or 120 mg/m2 of epirubicin (60FEC, 35 patients, vs 120FEC, 31 patients). 120FEC was supported by early primary G-CSF (days 4 to 13). Blood counts were obtained seven times during each course. The non-hematologic toxicity over 364 courses was similar in 60FEC and 120FEC. No cumulative hematologic toxicity was observed for white blood cells (WBC) and platelets (PLT), while for hemoglobin (Hb) a somewhat higher cumulative toxicity was observed with 120FEC than with 60FEC. W...
International journal of oncology, 2000
In metastatic breast cancer (MBC) doubling the epirubicin (EPI) dose intensity (DI) within the FE... more In metastatic breast cancer (MBC) doubling the epirubicin (EPI) dose intensity (DI) within the FEC (5-fluorouracil, EPI, cyclophosphamide) regimen could increase the response rate (RR) and ameliorate the quality of life (QoL) over standard FEC. From May, 1995, 74 consecutive patients with MBC were randomly treated with 6 courses of two FEC regimens containing 60 (60FEC) or 120 (120FEC, supported by primary G-CSF) mg/m2 of EPI. Drugs were administered every 21 days. The QoL was assessed over and after treatment by the EORTC QLQ-C30 (VER 2.0) and QLQ-BR23 questionnaires, compiled by the patient, and the Spitzer's QL-index, compiled by the physician. The study was prematurely closed in May, 1997, due to RR and QoL data of 4th interim analysis. The delivered EPI DI was 20.0 and 37.9 mg/m2/week in 60- and in 120FEC, respectively. Among the two regimens, there was no statistically significant difference in RR or in improvement of baseline overall QoL. With respect to 60FEC patients, t...
Pathologica, 1994
Eight new cases of Human Dirofilariasis in people living in Northern Italy were recorded: 3 from ... more Eight new cases of Human Dirofilariasis in people living in Northern Italy were recorded: 3 from the province of Asti and 2 from Alessandria (Piedmont), 1 from Corsico (Miland, Lombardy) and 2 from Ravenna (Emilia-Romagna). All the patients were adults, 42 to 66 years old, 4 men and 4 women. The localization of the nematode in all the cases was subcutaneous. Signs and symptoms were always mild and consisted in the growth of a 1 to 2 cm large nodule associated with occasional localized itching and oedema, sometimes with reddening. In one case, the sting of a non-specified winged insect was recorded in the anamnesis, in the same spot where the nodule developed. In another case, the nematode came out spontaneously from the lesion. The aetiological agent was always identified as Dirofilaria repens. These 8 new cases confirm the comparatively frequent presence of Human Dirofilariasis in regions of Northern Italy, namely in the Po Valley.
Minerva medica, Jan 10, 1983
The appearance of hypercalcemic syndrome during the course of lymphoma is not only an unusual eve... more The appearance of hypercalcemic syndrome during the course of lymphoma is not only an unusual event, but it puts a very difficult diagnostic and therapeutic question too. There are three aetiologic moments: the diffuse osseus metastases, the paraneoplastic syndrome and concomitant primitive hyperparathyroidism. The pathogenesis of these questions has lately stimulated a new kind of research, even if there are still a lot of unknown points. The Authors suggest, as their own contribution, the revision of the literature on this subject and they also suggest an acute hypercalcemic syndrome case brought about a primitive hyperparathyroidism in a patient suffering from Hodgkin's lymphoma.
Parassitologia, 1978
Adult females of Cheyletiella yasguri Smiley, 1965 were found in a dog parasitized by Otodectes c... more Adult females of Cheyletiella yasguri Smiley, 1965 were found in a dog parasitized by Otodectes cynotis, whose owners exhibited skin eruptions. C. yasguri is reported for the first time in the dog in Italy; the pathogenicity of this mite for both the dog and man has already been established by other authors.
Wildlife Diseases, 1976
Investigations on the incidence of rabies, leptospirae, salmonellae, dermatophytes, histoplasma, ... more Investigations on the incidence of rabies, leptospirae, salmonellae, dermatophytes, histoplasma, trichinella and intestinal helminths in 72 foxes of the Modenese Apennines are summarized.
42nd International Conference on Environmental Systems, 2012
Extravehicular activity (EVA) is one of the most critical enabling capabilities for human spacefl... more Extravehicular activity (EVA) is one of the most critical enabling capabilities for human spaceflight. Performing EVA is both technically challenging and physically demanding, requiring many hours of training and detailed preparation. As a result of working and training in the extravehicular mobility unit (EMU) spacesuit, many astronauts sustain musculoskeletal and minor injuries. Although injuries are typically minor and self-limited, they have the potential to impact mission success. We outline our research methodology to investigate EVA injury ultimately providing solutions that can be implemented both in the EMU and in future spacesuit designs. We review the issues and mechanisms causing injury as documented in the literature. The result of this work will be an injury database with input from many NASA stakeholders. We also highlight our work to model the astronaut performing realistic EVA motions to study the interaction between the person and the suit. Spacesuit models of the EMU and Mark III spacesuits will be used in combination with a human body model driven by the biomechanics of EVA motions. We will investigate joint torque, muscle activation, and contact pressure between the body and suit. This modeling effort informs our spacesuit injury countermeasure designs and recommendations. We present our design process for protection devices that ameliorate current astronaut suitinduced injuries.
Although metastatic breast cancer (MBC) is considered a chemosensitive tumour, its palliative tre... more Although metastatic breast cancer (MBC) is considered a chemosensitive tumour, its palliative treatment remains a challenge. Drug associations are usually employed as first line treatment, despite the controversy (Winer et al, 2001) as to whether combination chemotherapy does or does not provide greater antitumour effect than single agents used at appropriate dose levels (Sledge et al, 1997; Bishop et al, 1999; Nabholtz et al, 1999). Anthracycline-containing regimens, administered for 6-8 courses, are probably the first choice therapy in patients who have not received an anthracycline as adjuvant therapy. The association of doxorubicin or epirubicin with 5-fluorouracil and cyclophosphamide (FAC or FEC regimens) produces a higher response rate (RR) and longer time to progression than CMF-like regimens (Fossati et al, 1998), and a survival advantage is confirmed in the adjuvant setting (Coombes et al, 1996; Levine et al, 1998). From several trials on MBC, anthracycline-containing regimens produce a RR of about 65% (with a 16% rate of complete responses), a progression-free survival of 11.5 months and an overall survival of 21 months (Rahman et al, 1999). Ways of ameliorating the treatment of MBC have included increasing the drug dose-intensity, maintenance therapy and use of new drugs. No clear advantage has been obtained from doubling the anthracycline dose intensity within the FEC regimen (Biganzoli and Piccart, 1997; Riccardi et al, 2000). The relevance of continuing long-lasting combination chemotherapy following FEC, as a maintenance, is also largely unsettled. This approach has increased the time to progression, but the survival advantage was not significant and toxicity was increased (Muss et al, 1991; Falkson et al, 1998). New treatment opportunities to be explored come from the availability of new drugs that are both highly effective and not cross-resistant with the anthracyclines. Taxanes have substantial activity in previously treated patients (
Antarctica contains areas where the envtronment and temlin are more similar to regtons on the Moo... more Antarctica contains areas where the envtronment and temlin are more similar to regtons on the Moon and Mars than any other place on F.artb. 1bese features offer opportunities for simulations to determine peifonnance capabilities of people and machines in harsh, isolated locales. 1be Sasakawa International Center for space Architecture (S/CTA) plans to create a facility on Antarctica for research, planning, and demonstrations in suJPorl of planetary exploration. 1be Antarctic Pfanetary Testbed (APT) will be financed and utilized by pubHc and private organizations throughout the world F.stablisbed on a continent owned by no country, it can seroe as a model for cooperation between spacefarlng nations. APT science and technology programs will expand knowledge about the nature and origin of our solar system, and will suf1X»1 preparations for human settlements beyond F.artb that ""'i)' occur within the first quarter of the next century. 1be initial APT facUity, conceived to be operational by the year 1992, will be constructed during the summer months by a crew of approximately 12. Six to eight of these people will remain through the winter. As in space, structures and equipment systems will be modular to facilitate efficient transport to the site, assembly, and evolutionary expansion. State-ofthe.arl waste recovery/recycling systems are also emphasized due to their importance in space.
The Italian Journal of Neurological Sciences, 1992
Earth and Space 2021, 2021
The paper is concerned with the design of pneumatic structures which can be sent to the surface o... more The paper is concerned with the design of pneumatic structures which can be sent to the surface of the moon in a relatively small package and then opened to provide a large pressurized volume with life support systems to support a population of 12 people. A proposed system consists primarily of a Kevlar membrane which will support the internal pressures of the environment, a rigid pallet which will house all the life-support systems, and wall foam which provides sound and temperature insulation. The modules would be covered by three meters of lunar soil for radiation and temperature insulation. Site preparation, module connection, and characteristics of different modules are considered.
AIP Conference Proceedings, 2007
Revolutionary Design for Astronaut Exploration Beyond the Bio‐Suit System. [AIP Conference Proc... more Revolutionary Design for Astronaut Exploration Beyond the Bio‐Suit System. [AIP Conference Proceedings 880, 975 (2007)]. Dava J. Newman, Marita Canina, Guillermo L. Trotti. Abstract. ... In many respects, the Bio‐Suit System mimics Nature (biomimetics). ...
An architectural approach to the evolutionary growth of an orbiting space station from a small ma... more An architectural approach to the evolutionary growth of an orbiting space station from a small manned satellite to a fully independent, self-sustainable space colony facility is presented. Social and environmental factors, ease of transportation via the space shuttle, and structural design are considered.
42nd International Conference on Environmental Systems, 2012
Extravehicular activity (EVA) is one of the most critical enabling capabilities for human spacefl... more Extravehicular activity (EVA) is one of the most critical enabling capabilities for human spaceflight. Performing EVA is both technically challenging and physically demanding, requiring many hours of training and detailed preparation. As a result of working and training in the extravehicular mobility unit (EMU) spacesuit, many astronauts sustain musculoskeletal and minor injuries. Although injuries are typically minor and self-limited, they have the potential to impact mission success. We outline our research methodology to investigate EVA injury ultimately providing solutions that can be implemented both in the EMU and in future spacesuit designs. We review the issues and mechanisms causing injury as documented in the literature. The result of this work will be an injury database with input from many NASA stakeholders. We also highlight our work to model the astronaut performing realistic EVA motions to study the interaction between the person and the suit. Spacesuit models of the EMU and Mark III spacesuits will be used in combination with a human body model driven by the biomechanics of EVA motions. We will investigate joint torque, muscle activation, and contact pressure between the body and suit. This modeling effort informs our spacesuit injury countermeasure designs and recommendations. We present our design process for protection devices that ameliorate current astronaut suitinduced injuries.
2006 3rd IEEE/EMBS International Summer School on Medical Devices and Biosensors, 2006
... donning. This system is designed to be embedded in Bio-Suit, a revolutionary space suit conce... more ... donning. This system is designed to be embedded in Bio-Suit, a revolutionary space suit concept developed for many years by Prof. Dava ... exploration. I.Bio-SUIT SYSTEM The Bio-Suit System is a project developed by Prof. Dava ...
Extravehicular Activity (EVA) is among the most challenging activities in human spaceflight. Main... more Extravehicular Activity (EVA) is among the most challenging activities in human spaceflight. Maintaining astronaut health and comfort inside the spacesuit is critical to accomplish the tasks required for the mission. However, the current Extravehicular Mobility Unit (EMU) spacesuit causes many astronauts minor musculoskeletal injuries and discomfort, which could lead to suboptimal EVA performance and could impact mission success. This research effort highlights our effort to create a spacesuit injury and discomfort database to better track injuries and countermeasures. The database is developed as part of our broader investigation of " Spacesuit Trauma Countermeasure System Development ". The primary objective of the astronaut-spacesuit injury database is to gain insight into the mechanisms causing spacesuit injuries. The database is compiled from a variety of sources, such as existing databases and publications, oral histories, and astronaut debriefs. Once completely asse...
British Journal of Cancer, 1996
In a multicentre study, 83 patients with advanced and previously uniformly treated multiple myelo... more In a multicentre study, 83 patients with advanced and previously uniformly treated multiple myeloma (MM) were randomised between cyclophosphamide (600 mg m-2) and epirubicin (70 mg m-2), administered every 3 weeks for three courses and both associated with prednisone and interferon-a2b. Both regimens were administered on an outpatient basis and had low haematological toxicity. Clinical results were similar. Overall response rate (43%) and median response and survival (5.9 and 14.1 months respectively) compare well with those obtained with more aggressive chemotherapy schedules.
Tumori
The neutropenia induced by six courses of an intensified FEC regimen is expected to be checked by... more The neutropenia induced by six courses of an intensified FEC regimen is expected to be checked by early primary administration of G-CSF which is stopped eight days before the next chemotherapy course. Less information is available about megakaryocytic and erythroid toxicity over six courses. Sixty-six consecutive patients with metastatic breast cancer completed six courses of a randomized treatment with two FEC regimens administered every 21 days, in which 600 mg/m2 of cyclophosphamide and 5-FUwas associated with 60 or 120 mg/m2 of epirubicin (60FEC, 35 patients, vs 120FEC, 31 patients). 120FEC was supported by early primary G-CSF (days 4 to 13). Blood counts were obtained seven times during each course. The non-hematologic toxicity over 364 courses was similar in 60FEC and 120FEC. No cumulative hematologic toxicity was observed for white blood cells (WBC) and platelets (PLT), while for hemoglobin (Hb) a somewhat higher cumulative toxicity was observed with 120FEC than with 60FEC. W...
International journal of oncology, 2000
In metastatic breast cancer (MBC) doubling the epirubicin (EPI) dose intensity (DI) within the FE... more In metastatic breast cancer (MBC) doubling the epirubicin (EPI) dose intensity (DI) within the FEC (5-fluorouracil, EPI, cyclophosphamide) regimen could increase the response rate (RR) and ameliorate the quality of life (QoL) over standard FEC. From May, 1995, 74 consecutive patients with MBC were randomly treated with 6 courses of two FEC regimens containing 60 (60FEC) or 120 (120FEC, supported by primary G-CSF) mg/m2 of EPI. Drugs were administered every 21 days. The QoL was assessed over and after treatment by the EORTC QLQ-C30 (VER 2.0) and QLQ-BR23 questionnaires, compiled by the patient, and the Spitzer's QL-index, compiled by the physician. The study was prematurely closed in May, 1997, due to RR and QoL data of 4th interim analysis. The delivered EPI DI was 20.0 and 37.9 mg/m2/week in 60- and in 120FEC, respectively. Among the two regimens, there was no statistically significant difference in RR or in improvement of baseline overall QoL. With respect to 60FEC patients, t...
Pathologica, 1994
Eight new cases of Human Dirofilariasis in people living in Northern Italy were recorded: 3 from ... more Eight new cases of Human Dirofilariasis in people living in Northern Italy were recorded: 3 from the province of Asti and 2 from Alessandria (Piedmont), 1 from Corsico (Miland, Lombardy) and 2 from Ravenna (Emilia-Romagna). All the patients were adults, 42 to 66 years old, 4 men and 4 women. The localization of the nematode in all the cases was subcutaneous. Signs and symptoms were always mild and consisted in the growth of a 1 to 2 cm large nodule associated with occasional localized itching and oedema, sometimes with reddening. In one case, the sting of a non-specified winged insect was recorded in the anamnesis, in the same spot where the nodule developed. In another case, the nematode came out spontaneously from the lesion. The aetiological agent was always identified as Dirofilaria repens. These 8 new cases confirm the comparatively frequent presence of Human Dirofilariasis in regions of Northern Italy, namely in the Po Valley.
Minerva medica, Jan 10, 1983
The appearance of hypercalcemic syndrome during the course of lymphoma is not only an unusual eve... more The appearance of hypercalcemic syndrome during the course of lymphoma is not only an unusual event, but it puts a very difficult diagnostic and therapeutic question too. There are three aetiologic moments: the diffuse osseus metastases, the paraneoplastic syndrome and concomitant primitive hyperparathyroidism. The pathogenesis of these questions has lately stimulated a new kind of research, even if there are still a lot of unknown points. The Authors suggest, as their own contribution, the revision of the literature on this subject and they also suggest an acute hypercalcemic syndrome case brought about a primitive hyperparathyroidism in a patient suffering from Hodgkin's lymphoma.
Parassitologia, 1978
Adult females of Cheyletiella yasguri Smiley, 1965 were found in a dog parasitized by Otodectes c... more Adult females of Cheyletiella yasguri Smiley, 1965 were found in a dog parasitized by Otodectes cynotis, whose owners exhibited skin eruptions. C. yasguri is reported for the first time in the dog in Italy; the pathogenicity of this mite for both the dog and man has already been established by other authors.
Wildlife Diseases, 1976
Investigations on the incidence of rabies, leptospirae, salmonellae, dermatophytes, histoplasma, ... more Investigations on the incidence of rabies, leptospirae, salmonellae, dermatophytes, histoplasma, trichinella and intestinal helminths in 72 foxes of the Modenese Apennines are summarized.
42nd International Conference on Environmental Systems, 2012
Extravehicular activity (EVA) is one of the most critical enabling capabilities for human spacefl... more Extravehicular activity (EVA) is one of the most critical enabling capabilities for human spaceflight. Performing EVA is both technically challenging and physically demanding, requiring many hours of training and detailed preparation. As a result of working and training in the extravehicular mobility unit (EMU) spacesuit, many astronauts sustain musculoskeletal and minor injuries. Although injuries are typically minor and self-limited, they have the potential to impact mission success. We outline our research methodology to investigate EVA injury ultimately providing solutions that can be implemented both in the EMU and in future spacesuit designs. We review the issues and mechanisms causing injury as documented in the literature. The result of this work will be an injury database with input from many NASA stakeholders. We also highlight our work to model the astronaut performing realistic EVA motions to study the interaction between the person and the suit. Spacesuit models of the EMU and Mark III spacesuits will be used in combination with a human body model driven by the biomechanics of EVA motions. We will investigate joint torque, muscle activation, and contact pressure between the body and suit. This modeling effort informs our spacesuit injury countermeasure designs and recommendations. We present our design process for protection devices that ameliorate current astronaut suitinduced injuries.
Although metastatic breast cancer (MBC) is considered a chemosensitive tumour, its palliative tre... more Although metastatic breast cancer (MBC) is considered a chemosensitive tumour, its palliative treatment remains a challenge. Drug associations are usually employed as first line treatment, despite the controversy (Winer et al, 2001) as to whether combination chemotherapy does or does not provide greater antitumour effect than single agents used at appropriate dose levels (Sledge et al, 1997; Bishop et al, 1999; Nabholtz et al, 1999). Anthracycline-containing regimens, administered for 6-8 courses, are probably the first choice therapy in patients who have not received an anthracycline as adjuvant therapy. The association of doxorubicin or epirubicin with 5-fluorouracil and cyclophosphamide (FAC or FEC regimens) produces a higher response rate (RR) and longer time to progression than CMF-like regimens (Fossati et al, 1998), and a survival advantage is confirmed in the adjuvant setting (Coombes et al, 1996; Levine et al, 1998). From several trials on MBC, anthracycline-containing regimens produce a RR of about 65% (with a 16% rate of complete responses), a progression-free survival of 11.5 months and an overall survival of 21 months (Rahman et al, 1999). Ways of ameliorating the treatment of MBC have included increasing the drug dose-intensity, maintenance therapy and use of new drugs. No clear advantage has been obtained from doubling the anthracycline dose intensity within the FEC regimen (Biganzoli and Piccart, 1997; Riccardi et al, 2000). The relevance of continuing long-lasting combination chemotherapy following FEC, as a maintenance, is also largely unsettled. This approach has increased the time to progression, but the survival advantage was not significant and toxicity was increased (Muss et al, 1991; Falkson et al, 1998). New treatment opportunities to be explored come from the availability of new drugs that are both highly effective and not cross-resistant with the anthracyclines. Taxanes have substantial activity in previously treated patients (
Antarctica contains areas where the envtronment and temlin are more similar to regtons on the Moo... more Antarctica contains areas where the envtronment and temlin are more similar to regtons on the Moon and Mars than any other place on F.artb. 1bese features offer opportunities for simulations to determine peifonnance capabilities of people and machines in harsh, isolated locales. 1be Sasakawa International Center for space Architecture (S/CTA) plans to create a facility on Antarctica for research, planning, and demonstrations in suJPorl of planetary exploration. 1be Antarctic Pfanetary Testbed (APT) will be financed and utilized by pubHc and private organizations throughout the world F.stablisbed on a continent owned by no country, it can seroe as a model for cooperation between spacefarlng nations. APT science and technology programs will expand knowledge about the nature and origin of our solar system, and will suf1X»1 preparations for human settlements beyond F.artb that ""'i)' occur within the first quarter of the next century. 1be initial APT facUity, conceived to be operational by the year 1992, will be constructed during the summer months by a crew of approximately 12. Six to eight of these people will remain through the winter. As in space, structures and equipment systems will be modular to facilitate efficient transport to the site, assembly, and evolutionary expansion. State-ofthe.arl waste recovery/recycling systems are also emphasized due to their importance in space.
The Italian Journal of Neurological Sciences, 1992